Merck & Co., Inc., West Point, Pennsylvania 19486, United States.
Peptides and Small Molecules R&D Department, IRBM Spa, Via Pontina km 30.600, 00071 Pomezia (RM), Italy.
J Med Chem. 2022 Jan 13;65(1):485-496. doi: 10.1021/acs.jmedchem.1c01570. Epub 2021 Dec 21.
Inhibitor cystine knot peptides, derived from venom, have evolved to block ion channel function but are often toxic when dosed at pharmacologically relevant levels . The article describes the design of analogues of ProTx-II that safely display systemic blocking of Na1.7, resulting in a latency of response to thermal stimuli in rodents. The new designs achieve a better profile by improving ion channel selectivity and limiting the ability of the peptides to cause mast cell degranulation. The design rationale, structural modeling, profiles, and rat tail flick outcomes are disclosed and discussed.
抑制剂胱氨酸结肽来源于毒液,其进化目的是阻断离子通道功能,但在达到药理相关水平时通常具有毒性。本文描述了 ProTx-II 类似物的设计,该类似物可安全地表现出对 Na1.7 的全身性阻断,导致啮齿动物对热刺激的反应潜伏期。新设计通过提高离子通道选择性和限制肽引起肥大细胞脱颗粒的能力来改善性能。本文介绍并讨论了设计原理、结构建模、性能和大鼠尾巴敲击结果。